Obesity-Driven Variations in Endocrine Profiles among Polycystic Ovarian Syndrome Phenotypes in A Cross-Sectional Epidemiologic Study: Obesity and Metabolic Variations in PCOS

Soujanya J Pujar; Neelamma Patil

doi:10.55489/njcm.161220256014

Authors

Soujanya J Pujar Department of Obstetrics and Gynaecology Nursing, BLDEA’s Shri B M Patil Institute of Nursing Sciences, Vijayapura, Karnataka, India
Neelamma Patil Department of Obstetrics and Gynaecology, BLDE Deemed to be University, Shri B M Medical College, Hospital and Research Centre, Vijayapura, Karnataka, India

DOI:

https://doi.org/10.55489/njcm.161220256014

Keywords:

PCOS, Obesity, Lean, Clinical Parameters, BMI, Testosterone

Abstract

Background: The management approaches for polycystic ovary syndrome (PCOS) vary between lean and overweight patients which led to this research investigating clinical and endocrine differences among lean and obese/ overweight PCOS individuals. Objective was to evaluate the clinical and hormonal differences between obese/ overweight and lean phenotypes of women with PCOS.

Methods and Materials: The study executed between January 2021 and March 2022 at B M Patil Medical College and Hospital in Vijayapur, included 77 women aged 21-35 who met the Rotterdam criteria for PCOS diagnosis. Participants were dichotomized as lean (≤23 kg/m²) or obese/ overweight (>23 kg/m²), with the sociodemographic information collected as well as clinical assessments and hormone measurements.

Results: The 77 participants comprised 33 lean and 44 obese/ overweight individuals. Lean women experienced more irregular menstrual cycles, while obese/overweight women had higher rates of dysmenorrhea. Waist-hip ratios differed significantly, with 60.6% of lean women having a ratio ≤0.8 and 86.4% of obese/ overweight women exceeding 0.8. Hirsutism and acne were more prevalent in obese/ overweight individuals, with statistical significance. Lean women had higher proportion of elevated free testosterone levels (>6.3pg/mL) at 39% compared to 22.7% of obese/overweight women had a higher proportion. Obese/ overweight women had a higher proportion of LH: FSH ratios ≥1(59.1%) compared to lean participants (45.5%).

Conclusion: The findings highlight the clinical and hormonal disparities between lean and obese/overweight PCOS patients, underscoring the importance of BMI in PCOS management. Limitations include the small size and lack of multivariate analysis, which may affect generalizability and control for confounding variables.

References

Veltman-Verhulst SM, Boivin J, Eijkemans M, Fauser B. Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies. Hum Reprod Update. 2012;18(6):638-651. DOI: https://doi.org/10.1093/humupd/dms029 PMid:22824735

Kiałka M, Milewicz T, Sztefko K, Rogatko I, Majewska R. History of discovery of polycystic ovary syndrome. Adv Clin Exp Med. 2017; 26(3):555-558. DOI: https://doi.org/10.17219/acem/61987 PMid:28791833

Bonnar J, Dunlop W. Recent advances in obstetrics and gynaecology. 23rd ed. London: Royal Society of Medicine; 2005.

Xita N, Georgiou I, Tsatsoulis A. The genetic basis of polycystic ovary syndrome. Eur J Endocrinol. 2002;147(6):717-725. DOI: https://doi.org/10.1530/eje.0.1470717 PMid:12457445

Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009;30(4):293-342. DOI: https://doi.org/10.1210/er.2009-0002 PMid:19502515 PMCid:PMC2726844

Dumesic DA, Abbott DH, Sanchita Sharma, Chazenbalk GD. Endocrine-Metabolic Dysfunction in Polycystic Ovary Syndrome: an Evolutionary Perspective. Curr Opin Endocr Metab Res. 2020;12:41-48. DOI: https://doi.org/10.1016/j.coemr.2020.02.013 PMid:32363240 PMCid:PMC7194185

Teede HJ, Joham AE, Paul E, et al. Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Obesity (Silver Spring). 2013;21(8):1526-1532. DOI: https://doi.org/10.1002/oby.20213 PMid:23818329

Jahan S, Munir F, Razak S, et al. Ameliorative effects of rutin against metabolic, biochemical and hormonal disturbances in polycystic ovary syndrome in rats. J Ovarian Res. 2016; 9(1):86. DOI: https://doi.org/10.1186/s13048-016-0295-y PMid:27923406 PMCid:PMC5142269

Henney AE, Gillespie CS, Lai JY, et al. Risk of Type 2 Diabetes, MASLD and Cardiovascular Disease in People Living With Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2025;110(5):1235-1246. DOI: https://doi.org/10.1210/clinem/dgae481 PMid:38986027 PMCid:PMC12012816

Idicula-Thomas S, Gawde U, Bhaye S, Pokar K, Bader GD. Meta-analysis of gene expression profiles of lean and obese PCOS to identify differentially regulated pathways and risk of comorbidities. Comput Struct Biotechnol J. 2020;18:1735-1745. DOI: https://doi.org/10.1016/j.csbj.2020.06.023 PMid:32695266 PMCid:PMC7352056

Mohan D, Pradeepa R, Venkatesan U et al. High prevalence of metabolic obesity in India: The ICMR-INDIAB national study (ICMR-INDIAB-23). Indian J Med Res. 2025 May;161(5):461-472. DOI: https://doi.org/10.25259/IJMR_328_2025. PMID: 40844097 PMCID: PMC12550443

Carmina E, Lobo RA. Comparing Lean and Obese PCOS in Different PCOS Phenotypes: Evidence That the Body Weight Is More Important Than the Rotterdam Phenotype in Influencing the Metabolic Status. Diagnostics. 2022; 12(10):2313. DOI: https://doi.org/10.3390/diagnostics12102313 PMid:36292002 PMCid:PMC9600591

WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363(9403):157-163. DOI: https://doi.org/10.1016/S0140-6736(03)15268-3 PMid:14726171

Kahraman FC, Erdoğan SS. Grading of hirsutism: a practical approach to the modified Ferriman-Gallwey scoring system. Postepy Dermatol Alergol. 2022; 39(4):744-748. DOI: https://doi.org/10.5114/ada.2021.108455 PMid:36090715 PMCid:PMC9454347

Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016; 37(5):467-520. DOI: https://doi.org/10.1210/er.2015-1104 PMid:27459230 PMCid:PMC5045492

Choudhary A, Jain S, Chaudhari P. Prevalence and symptomatology of polycystic ovarian syndrome in Indian women: is there a rising incidence? Int J Repro'd Contracept Boster Gynecol. 2017; 6(11):4971- 4975. DOI: https://doi.org/10.18203/2320-1770.ijrcog20175010

Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27-36. DOI: https://doi.org/10.1016/j.jsbmb.2018.04.008 PMid:29678491

Goyal M, Dawood AS. Debates Regarding Lean Patients with Polycystic Ovary Syndrome: A Narrative Review. J Hum Reprod Sci. 2017 Jul-Sep;10(3):154-161. DOI: https://doi.org/10.4103/jhrs.JHRS_77_17 PMid:29142442 PMCid:PMC5672719

Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(6):618-637. DOI: https://doi.org/10.1093/humupd/dms030 PMid:22767467

Alvarez-Blasco F, Botella-Carretero JI, San Millán JL, Escobar-Morreale HF. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch Intern Med. 2006;166(19):2081-2086. DOI: https://doi.org/10.1001/archinte.166.19.2081 PMid:17060537

Makhija N, Tayade S, Toshniwal S, Tilva H. Clinico-metabolic profile in lean versus obese polycystic ovarian syndrome women. Cureus. 2023;15(4):e37809. DOI: https://doi.org/10.7759/cureus.37809

Mohapatra I, Samantaray SR. BMI and Polycystic Ovary Syndrome: Demographic Trends in Weight and Health. Cureus. 2024;16(3):e55439. DOI: https://doi.org/10.7759/cureus.55439

McCartney CR, Campbell RE. Abnormal GnRH Pulsatility in Polycystic Ovary Syndrome: Recent Insights. Curr Opin Endocr Metab Res. 2020;12:78-84. DOI: https://doi.org/10.1016/j.coemr.2020.04.005 PMid:32676541 PMCid:PMC7365617

Okigbo CC, Gill S, Hall JE. The Hypothalamic-Pituitary Axis in PCOS. In: Polycystic Ovary Syndrome. Springer; 2022;73-93. DOI: https://doi.org/10.1007/978-3-030-92589-5_5

Barbotin AL, Mimouni NEH, Kuchcinski G, et al. Hypothalamic neuroglial plasticity is regulated by anti-Müllerian hormone and disrupted in polycystic ovary syndrome. E-BioMedicine. 2023; 90:104535. DOI: https://doi.org/10.1016/j.ebiom.2023.104535 PMid:37001236 PMCid:PMC10070524

Abbott DH, Hutcherson BA, Dumesic DA. Anti-Müllerian Hormone: A Molecular Key to Unlocking Polycystic Ovary Syndrome? Semin Reprod Med. 2024 Mar;42(1):41-48. DOI: https://doi.org/10.1055/s-0044-1787525 PMid:38908381 PMCid:PMC12107497

Liao B, Qiao J, Pang Y. Central Regulation of PCOS: Abnormal Neuronal-Reproductive-Metabolic Circuits in PCOS Pathophysiology. Front Endocrinol (Lausanne). 2021;12:667422. DOI: https://doi.org/10.3389/fendo.2021.667422 PMid:34122341 PMCid:PMC8194358

Benyaminpour S, Sachmechi I. PCOS and Acne: A Systematic Review. Int J Clin Med Case Rep. 2024;37: 000906. DOI: https://doi.org/10.46998/IJCMCR.2024.37.000906

Akshaya S, Bhattacharya R.Comparative study of clinical profile of lean and obese polycystic ovary syndrome women. Int J Reprod Contracept Obstet Gynecol. 2017;11;5(8):2530-2533. DOI: https://doi.org/10.18203/2320-1770.ijrcog20162173

Kiddy DS, Sharp PS, White DM, Scanlon MF, Mason HD, Bray CS. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: An analysis of 263 consecutive cases. Clinical Endocrinology. 1990;32(2):213-220. DOI: https://doi.org/10.1111/j.1365-2265.1990.tb00857.x PMid:2112067

Kumar N, Agarwal H. Early Clinical, Biochemical and Radiological Features in Obese and Non-Obese Young Women with Polycystic Ovarian Syndrome: A Comparative Study. Horm Metab Res. 2022; 54(9):620-624. DOI: https://doi.org/10.1055/a-1880-1264 PMid:35858631

Remsberg KE, Talbott EO, Zborowski JV, Evans RW, McHugh-Pemu K. Evidence for competing effects of body mass, hyperinsulinemia, insulin resistance, and androgens on leptin levels among lean, overweight, and obese women with polycystic ovary syndrome. Fertil Steril. 2002;78(3):479-486. DOI: https://doi.org/10.1016/S0015-0282(02)03303-4 PMid:12215321

Quennell JH, Mulligan AC, Tups A, et al. Leptin indirectly regulates gonadotropin-releasing hormone neuronal function. Endocrinology. 2009;150(2):772-779. DOI: https://doi.org/10.1210/en.2008-1693 PMid:19179437 PMCid:PMC2732287

Nayak PK, Mitra S, Sahoo J, Mahapatra E, Agrawal S, Lone Z. Relationship of subclinical hypothyroidism and obesity in polycystic ovarian syndrome patients. J Family Med Prim Care. 2020; 9(1):147-150. DOI: https://doi.org/10.4103/jfmpc.jfmpc_654_19 PMid:32110581 PMCid:PMC7014912